| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
18,898 |
17,264 |
$1.19M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
6,909 |
6,682 |
$582K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,905 |
10,154 |
$544K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
5,225 |
5,163 |
$325K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
6,585 |
6,102 |
$204K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,928 |
1,802 |
$78K |
| 99215 |
Prolong outpt/office vis |
568 |
542 |
$58K |
| 99058 |
|
929 |
827 |
$50K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,135 |
4,034 |
$44K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,152 |
1,580 |
$38K |
| 99000 |
|
7,444 |
6,953 |
$23K |
| 71046 |
Radiologic examination, chest; 2 views |
1,719 |
1,567 |
$22K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,756 |
1,639 |
$13K |
| 86328 |
|
167 |
164 |
$6K |
| 99205 |
Prolong outpt/office vis |
32 |
31 |
$4K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
521 |
474 |
$4K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
109 |
102 |
$3K |
| 81002 |
|
1,814 |
1,680 |
$3K |
| 73630 |
|
208 |
181 |
$3K |
| 81003 |
|
1,644 |
1,602 |
$2K |
| 81025 |
|
537 |
517 |
$2K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
52 |
52 |
$2K |
| 73130 |
|
140 |
137 |
$2K |
| 93000 |
|
248 |
238 |
$2K |
| S9083 |
Global fee urgent care centers |
2,338 |
2,101 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
756 |
715 |
$1K |
| 74022 |
|
41 |
38 |
$791.77 |
| 73610 |
|
57 |
57 |
$782.65 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
451 |
425 |
$639.72 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
40 |
39 |
$485.50 |
| 73564 |
|
24 |
24 |
$399.42 |
| 73110 |
|
15 |
14 |
$263.45 |
| 74019 |
|
19 |
17 |
$252.33 |
| 86308 |
|
59 |
57 |
$202.19 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
45 |
42 |
$199.87 |
| 87807 |
|
25 |
25 |
$193.30 |
| 69210 |
|
14 |
12 |
$177.71 |
| 87430 |
|
35 |
17 |
$152.38 |
| 73562 |
|
16 |
13 |
$143.80 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
12 |
12 |
$70.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
73 |
68 |
$52.13 |
| 82962 |
|
25 |
25 |
$48.78 |
| 99072 |
|
210 |
198 |
$25.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
66 |
54 |
$0.06 |
| 99173 |
|
14 |
12 |
$0.00 |
| J7610 |
Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg |
15 |
13 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
14 |
14 |
$0.00 |
| 94760 |
|
16 |
16 |
$0.00 |